Related Experiment Video
Updated: Mar 6, 2026
08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
7.3K
Pancreatic Cancer Genomics 2.0: Profiling Metastases
Eric A Collisson1, Anirban Maitra2
1Helen Diller Comprehensive Cancer Center, Department of Medicine, University of California San Francisco, San Francisco, CA 94158, USA.
Cancer Cell
|March 16, 2017
Summary
Pancreatic ductal adenocarcinoma frequently metastasizes early due to mutations and genomic instability. Recent studies reveal how cancer genomes evolve during metastasis from the pancreas to distant sites.
Area of Science:
- Oncology
- Genomics
- Cancer Biology
Background:
- Pancreatic ductal adenocarcinoma (PDAC) is characterized by early and widespread metastasis, even at initial diagnosis.
- Genomic instability and recurrent mutations are recognized as early drivers of PDAC progression.
Purpose of the Study:
- To elucidate the genomic evolutionary trajectory of pancreatic ductal adenocarcinoma during the metastatic process.
- To understand how primary tumor evolution facilitates colonization of distant organs.
Main Methods:
- Comparative genomic analysis of primary and metastatic PDAC samples.
- Identification of key mutations and genomic alterations associated with metastatic potential.
Main Results:
- Early genomic alterations in primary tumors are linked to subsequent metastatic dissemination.
- Specific mutational signatures and copy number variations are enriched in metastatic lesions.
- The evolution of the cancer genome during migration from the pancreas to secondary sites is characterized by accumulating genetic changes.
Conclusions:
- Understanding cancer genome evolution in PDAC metastasis is crucial for developing targeted therapies.
- Early genomic events significantly influence the metastatic cascade in pancreatic cancer.
- Further research into PDAC genomic evolution can identify biomarkers for early detection and treatment strategies.
